Prescription Patterns and Testosterone Concentrations Achieved With AndroForte 5% Testosterone Cream in Transgender and Gender Diverse Individuals

BJ Nolan; S Zwickl; P Locke; S Simpson; L Li; JD Zajac; AS Cheung

Journal article

Prescription Patterns and Testosterone Concentrations Achieved With AndroForte 5% Testosterone Cream in Transgender and Gender Diverse Individuals

BJ Nolan, S Zwickl, P Locke, S Simpson, L Li, JD Zajac, AS Cheung

Journal of Sexual Medicine | Published : 2022

DOI: 10.1016/j.jsxm.2022.02.020

Abstract

Background: Masculinizing hormone therapy with testosterone is used to align an individual's physical characteristics with their gender identity in trans and gender diverse individuals. Standard testosterone doses and formulations recommended for hypogonadal cisgender men are typically administered. 100 mg AndroForte 5% testosterone cream is the recommended starting dose in hypogonadal cisgender men but there are no data evaluating the use of AndroForte 5% testosterone cream in gender-affirming hormone therapy regimens. Aim: To assess the prescription patterns and serum total testosterone concentrations achieved with AndroForte 5% testosterone cream in trans and gender diverse individuals. M..

View full abstract

University of Melbourne Researchers

Related Projects (2)

EFFECTS OF TESTOSTERONE AND OESTROGEN ON BODY COMPOSITION

Masculinising and feminising hormones such as testosterone and oestrogen respectively are important hormones controlling the amount of muscl..

Safety and quality of life of peri-operative transdermal estradiol continuation during gender affirmation surgery in transgender women: a randomised placebo-controlled trial

Despite no clear evidence, transgender women are told to stop their feminising estrogen treatment several weeks before gender surgery, but t..

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

No funding was received for this project. BJN is a recipient of an Australian Government National Health and Medical Research Council Postgraduate Scholarship (#2003939). ASC is supported by a National Health and Medical Research Council Early Career Fellowship (#1143333) atnd Investigator Grant (#2008956).